Ledger.Open graph →
SEC Form D · filed July 17, 2024

Belenos Biosciences, Inc

Offering
$55.0M
Sold
$48.0M
Exemption
Rule 506(b)
Industry
Other
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Carl L. Gordon · New York, NYDirectorDavid D. Wang · New York, NYDirectorBo D. Chen · New York, NYDirectorTania D. Dimitrova · New York, NYExecMegan D. Dow · New York, NYExecStjohn D. Mcgrath · New York, NYExec · DirectorBo D. Chen · New York, NYDirectorTania D. Dimitrova · New York, NYExecDavid D. Wang · New York, NYDirectorMegan D. Dow · New York, NYExecStjohn D. Mcgrath · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗